Clinical trials
Dementia trials in Germany with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2008 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Recruiting | 2 |
| Unknown status | 2 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| German Center for Neurodegenerative Diseases (DZNE) | 6 |
| Charite University, Berlin, Germany | 3 |
| Martin-Luther-Universität Halle-Wittenberg | 2 |
| Technische Universität Dresden | 2 |
| University of Ulm | 2 |
| Anglia Ruskin University | 1 |
| Heidelberg University | 1 |
| NORCE Norwegian Research Centre AS | 1 |
| Professor Johannes Pantel | 1 |
| Technical University of Munich | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dementia | 25 |
| Cognitive Dysfunction | 8 |
| Alzheimer Disease | 2 |
| Dementia, Vascular | 2 |
| Lewy Body Disease | 2 |
| Mixed Dementias | 2 |
| Neurodegenerative Diseases | 2 |
| Parkinson Disease | 2 |
| Basal Ganglia Diseases | 1 |
| Brain Diseases | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.